Antipsychotic and opioid agonist treatments that are prescribed as part of an integrated model of care may increase antipsychotic adherence, according to a study published in Schizophrenia Research.
https://www.psychiatryadvisor.com/home/schizophrenia-advisor/antipsychotic-adherence-twice-as-likely-when-preceded-by-methadone-adherence/